01 Aug 2025

Metastatic Breast Cancer Study

Trial overview

Disease

Metastatic Breast Cancer

Sponsor

Enquire

Description

A Multicenter, Open-Label, Single-Arm, Phase II Trial Exploring the Maintenance of Trastuzumab and Pertuzumab Following Trastuzumab Deruxtecan as Induction Treatment for HER2-positive Unresectable Locally Advanced or Metastatic Breast Cancer Patient

Study details

For detailed information on this trial, please click here

Trial status

Opening September 2025

Location

Bristol

Principal Investigator

Dr Tim Robinson

BMedSci (Hons) BMBS (Hons) PgDip (Onc) PhD FHEA MRCP (Onc)

Consultant Senior Lecturer and Honorary Medical Oncologist